JP2023544249A5 - - Google Patents
Info
- Publication number
- JP2023544249A5 JP2023544249A5 JP2023515723A JP2023515723A JP2023544249A5 JP 2023544249 A5 JP2023544249 A5 JP 2023544249A5 JP 2023515723 A JP2023515723 A JP 2023515723A JP 2023515723 A JP2023515723 A JP 2023515723A JP 2023544249 A5 JP2023544249 A5 JP 2023544249A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- composition according
- ribitol
- disorder
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063076761P | 2020-09-10 | 2020-09-10 | |
| US63/076,761 | 2020-09-10 | ||
| PCT/US2021/049677 WO2022056137A1 (en) | 2020-09-10 | 2021-09-09 | Ribitol treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023544249A JP2023544249A (ja) | 2023-10-23 |
| JP2023544249A5 true JP2023544249A5 (https=) | 2024-09-11 |
Family
ID=80629815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023515723A Pending JP2023544249A (ja) | 2020-09-10 | 2021-09-09 | リビトール治療 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230364118A1 (https=) |
| EP (1) | EP4210708A4 (https=) |
| JP (1) | JP2023544249A (https=) |
| KR (1) | KR20230069941A (https=) |
| CN (1) | CN117355310A (https=) |
| AU (1) | AU2021338706A1 (https=) |
| CA (1) | CA3191582A1 (https=) |
| IL (1) | IL301088A (https=) |
| MX (1) | MX2023001881A (https=) |
| WO (1) | WO2022056137A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10434113B2 (en) | 2016-12-16 | 2019-10-08 | The Charlotte Mecklenburg Hospital Authority | Compositions and methods for treating muscular dystrophy and other disorders |
| AU2020283556A1 (en) | 2019-05-28 | 2022-01-06 | The Charlotte-Mecklenburg Hospital Authority D/B/A Atrium Health | Compositions and methods of making ribitol |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10245235B2 (en) * | 2016-12-16 | 2019-04-02 | The Charlotte-Mecklenburg Hospital Authority | Compositions and methods for treating muscular dystrophy and other disorders |
| US20200061092A1 (en) * | 2018-08-24 | 2020-02-27 | The Charlotte Mecklenburg Hospital Authority D/B/A Atrium Health | Methods and compositions for treating disorders associated with muscle weakness |
-
2021
- 2021-09-09 AU AU2021338706A patent/AU2021338706A1/en active Pending
- 2021-09-09 IL IL301088A patent/IL301088A/en unknown
- 2021-09-09 WO PCT/US2021/049677 patent/WO2022056137A1/en not_active Ceased
- 2021-09-09 MX MX2023001881A patent/MX2023001881A/es unknown
- 2021-09-09 CN CN202180073484.0A patent/CN117355310A/zh active Pending
- 2021-09-09 US US18/044,747 patent/US20230364118A1/en active Pending
- 2021-09-09 CA CA3191582A patent/CA3191582A1/en active Pending
- 2021-09-09 JP JP2023515723A patent/JP2023544249A/ja active Pending
- 2021-09-09 KR KR1020237010497A patent/KR20230069941A/ko active Pending
- 2021-09-09 EP EP21867600.5A patent/EP4210708A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024074963A5 (https=) | ||
| Reimherr et al. | A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients | |
| RU2707089C2 (ru) | Комбинированная композиция | |
| JPH0222229A (ja) | 神経細胞及び神経繊維の疾患もしくは傷害の治療に用いる組み合わせ調合剤 | |
| JP2001513487A5 (https=) | ||
| JP2023544249A5 (https=) | ||
| JP2023531679A5 (https=) | ||
| WO2024160030A1 (zh) | 一种组合物及其在制备治疗神经性疼痛药物中的应用 | |
| JP2022553888A5 (https=) | ||
| JP2004525940A (ja) | 火照りの処置のためのデュロキセチン | |
| EA004474B1 (ru) | Комбинированное лечение заболевания цнс, особенно болезни паркинсона, путём совместного введения каберголина и прамипексола | |
| RU2192252C2 (ru) | Применение прамипексола в лечении синдрома усталых ног | |
| JP2004091473A (ja) | 色素沈着改善治療薬 | |
| JPH01261334A (ja) | アンギオテンシン転換酵素阻害剤を有効成分とした医療用調剤及びその製造方法 | |
| JP2021530568A5 (https=) | ||
| Bolte et al. | Case of fluoxetine-induced remission of Raynaud's phenomenon—a case report | |
| JP2025522146A5 (https=) | ||
| RU2003100081A (ru) | Способы и композиции, в которых используется сулодексид, для лечения диабетической нефропатии | |
| JP2024531799A5 (https=) | ||
| JP2022546042A5 (https=) | ||
| JP7312286B2 (ja) | うつ病を予防または治療するための安息香酸またはその塩および誘導体 | |
| EP2340026B1 (en) | A deproteinised calf blood preparation for use in prevention or treatment of diabetic peripheral polyneuropathy | |
| Han | Safety of Topical Calcineurin Inhibitors for Hailey-Hailey Disease | |
| JP2018177773A (ja) | 医薬 | |
| JP2024518455A5 (https=) |